0.12 AUD
0
0%
Last update Dec 16, 10:00 AM AEDT
Market closed
Day range
0.12
0.12
Previous close
0.12000000
Open
0.12
Access this stock data via API
Subscribe
Invex Therapeutics Limited
0.12
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue
Cost of revenue
Gross profit
Operating expense
Research & development 204.5K 1.8M 6.8M 2.1M
Selling general and admin 491.9K 1.1M 1.9M 1.7M
Other operating expenses 254.8K 449.5K 292.5K 378.7K
Operating income -951.2K -3.3M -9.0M -4.2M
Non operating interest income
Income 232.4K 491.8K 797.1K 79.9K
Expense
Other income expense 241.9K 1.2M 432.3K 208.7K
Pretax income -476.9K -1.6M -7.7M -4.0M
Tax provision 0 0 0 0
Net income -476.9K -1.6M -7.7M -4.0M
Basic EPS 0.0 -0.1 -0.1
Diluted EPS 0.0 -0.1 -0.1
Basic average shares 75.2M 75.2M 75.2M
Diluted average shares 75.2M 75.2M 75.2M
EBITDA -951.2K -3.3M -9.0M -4.2M
Net income from continuing op.
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 12 hours 2 minutes

18:57
00:00
10:00
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 10:00
Main market
10:00 - 16:00
Post-market
16:00 - 16:12
All times are displayed in the Australia/Sydney timezone (AEDT, UTC+11:00).